NasdaqCM:NKTRPharmaceuticals
What Nektar Therapeutics (NKTR)'s US$110 Million Equity Offering Means For Shareholders
Nektar Therapeutics has recently announced multiple shelf registration filings and a follow-on equity offering for up to US$110 million in common stock, with additional shelf registrations covering various other securities and an ESOP-related offering, after updating investors on new study data and regulatory milestones for rezpegaldesleukin.
This series of capital-raising initiatives signals the company's intent to strengthen its financial position, which may alter its funding runway and...